Keyword: Purdue Pharma

Alder hires Juno exec as CEO, Allergan brings in Abbott vet after investors demand change, and ResTORbio poaches Novartis researcher as clinical VP.

New clinical trial results of Eisai and Purdue's lemborexant suggest it could become a new force in the sleep disorder market, say the partners.

Former Ariad CEO leads Roivant and Arbutus' new RNA JV, Purdue Pharma names new R&D head, Immunomedics poaches AZ I-O exec as R&D chief.

Japanese pharma Eisai and traditional pain biopharma Purdue have posted positive late-stage results from their partnered sleep medication lemborexant.

Meyers retires as Gilead's commercial head, Kewalramani was promoted to Vertex's CMO, Recipharm CFO Stenqvist jumped ship to Sobi.

Struggling Teva bid farewell to longtime CFO Eyal Desheh, Immune Pharma's CEO Teper departed and Rgenix tapped ex-Novartis oncology scientist as CMO.

Purdue has signed a new deal with Japanese drugmaker Shionogi that will see the pair work together to sell in the U.S. the latter’s opioid-induced constipation candidate Symproic (naldemedine).

Exicure just signed up its first partnership deal, with Purdue offering up to $790 million for rights to its lead psoriasis drug and other projects.